Publications by authors named "A J Baca-Osorio"
Efficacy of a joint didactic intervention using the Junta De Andalucía School for Patients method to control prothrombin time in patients taking anticoagulants: protocol for a randomized controlled trial.
Trials
January 2021
Background: Oral anticoagulant drugs represent an essential tool in the prevention of thromboembolic events. The ones in widespread use are vitamin K antagonists, whose plasma level is monitored by measuring prothrombin time using the international normalized ratio. If its values are out of the recommended range, the patient will have a higher risk of suffering from thromboembolic or hemorrhagic complications.
View Article and Find Full Text PDFObjective: To examine the impact of an intervention by Primary Care (PC) professionals of a Health District on the clinical outcomes for treating COPD exacerbations using a process and outcome indicators analysis (clinical audit).
Design: Observational, retrospective and prospective analysis cross-sectional audit of clinical practice SETTING: Malaga-Guadalhorce Sanitary District (DSMG).
Participants: Patients with COPD exacerbations treated by the extra-hospital emergency services (n=523; 21% losses).
Background: The impact of a lifestyle intervention (LSI) program for the long-term management of subjects with metabolic syndrome in a primary care setting is not known.
Methods: This 3-year prospective controlled trial randomized adult subjects with metabolic syndrome to receive intensive LSI or to usual care in a community health centre in Malaga, Spain. LSI subjects received instruction on Mediterranean diet and a regular aerobic exercise program by their primary care professionals.
Introduction: The aim of the study is to describe the pattern of use of hypoglycemic agents in a primary health care district of Málaga between the years 2008-2012.
Material And Method: Cross-sectional descriptive study. Málaga health district.
Article Synopsis
- The study investigates how HbA1c levels correlate with chronic kidney disease (CKD) and cardiovascular disease (CVD) in adults, even those who don't have diabetes.
- Results showed that higher HbA1c levels were linked to worse kidney and heart health, and a one-point increase in HbA1c raised the risk of CKD or CVD by 30-40%.
- The findings highlight HbA1c as an important indicator for assessing cardiovascular and renal diseases in the general population, suggesting it's useful beyond just diabetes risk.